
     RDKit          3D

 11 12  0  0  0  0  0  0  0  0999 V2000
    2.0560    1.0290    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2430   -0.3630   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1910   -1.1820   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1370   -0.6650   -0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2630    0.7310   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7470    1.5310   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4742   -0.8660   -0.0087 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2460   -1.4220    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5770   -0.7040    0.0010 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0160    1.0430   -0.0000 B   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7897    2.3280    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  2  7  1  0
  3  4  2  0
  4  5  1  0
  4  8  1  0
  5  6  2  0
  5 10  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
M  END
>  <DRUGBANK_ID>  (1) 
DB09041

>  <SECONDARY_ACCESSION_NUMBERS>  (1) 
DB05058

>  <COMMON_NAME>  (1) 
Tavaborole

>  <CAS_NUMBER>  (1) 
174671-46-6

>  <UNII>  (1) 
K124A4EUQ3

>  <SYNONYMS>  (1) 
5-Fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole; 5-Fluoro-2,1-benzoxaborol-1(3H)-ol; Tavaborole

$$$$
